[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]
Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020
Giulia Pullano1, Francesco Pinotti1, Eugenio Valdano2, Pierre-Yves Boëlle1, Chiara Poletto1, Vittoria Colizza1
Affiliations: 1 INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, Paris, France; 2 Center for Biomedical Modeling, The Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, United States
Correspondence: Vittoria Colizza
Citation style for this article: Pullano Giulia, Pinotti Francesco, Valdano Eugenio, Boëlle Pierre-Yves, Poletto Chiara, Colizza Vittoria. Novel coronavirus (2019-nCoV) early-stage importation risk to Europe, January 2020. Euro Surveill. 2020;25(4):pii=2000057. https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000057
Received: 23 Jan 2020; Accepted: 30 Jan 2020
Abstract
As at 27 January 2020, 42 novel coronavirus (2019-nCoV) cases were confirmed outside China. We estimate the risk of case importation to Europe from affected areas in China via air travel. We consider travel restrictions in place, three reported cases in France, one in Germany. Estimated risk in Europe remains high. The United Kingdom, Germany and France are at highest risk. Importation from Beijing and Shanghai would lead to higher and widespread risk for Europe.
© This work is licensed under a Creative Commons Attribution 4.0 International License.
–
Keywords: 2019-nCoV; European Region.
——-
ETIDIoH 